Full-size panel discussions featuring expert insights, opinions, and perspectives on key issues facing today's payers, providers, and patients.
Access Considerations for Gene Therapies Among Patients With Rare Diseases
December 14th 2023A panel of experts provide an overview of gene therapy, review recently approved gene therapies for rare diseases such as hemophilia, spinal muscular atrophy, and Duchenne muscular dystrophy, and discuss managed care considerations, focusing on the growing pipeline of therapies.
Read More